Jurgen M J Piek
Overview
Explore the profile of Jurgen M J Piek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brink G, Groeneweg J, Sickinghe A, Nijman H, van Lonkhuijzen L, Lok C, et al.
J Ovarian Res
. 2025 Feb;
18(1):37.
PMID: 39987174
Background: As current literature does not provide sufficient data to support clear guidelines in patients with a rare adult-type granulosa cell tumor, we aim to investigate: (1) whether additional staging...
2.
van Erp M, van Odenhoven A, Burger J, Ayez N, Ezendam N, Boll D, et al.
Int J Gynecol Cancer
. 2025 Jan;
35(1):100014.
PMID: 39878272
No abstract available.
3.
Fisch C, Gelderblom M, Hermens R, de Reuver P, Nienhuijs S, Somford D, et al.
BJS Open
. 2025 Jan;
9(1).
PMID: 39871731
Background: Ovarian cancer is the leading cause of death among gynaecological cancers. The identification of the fallopian tube epithelium as the origin of most ovarian cancers introduces a novel prevention...
4.
Van Bommel M, Steenbeek M, IntHout J, Van Garderen T, Harmsen M, Arts-De Jong M, et al.
BJOG
. 2025 Jan;
PMID: 39823150
Objective: To compare menopause-related quality of life (QoL) after risk-reducing salpingectomy (RRS) versus risk-reducing salpingo-oophorectomy (RRSO) until 3 years of post-surgery. Design: A prospective study (TUBA study) with treatment allocation...
5.
Hendrikse C, Theelen P, Verhaegh W, Lambrechts S, Bekkers R, van de Stolpe A, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682227
: Advances in treatment options have barely improved the prognosis of ovarian carcinoma (OC) in recent decades. The inherent heterogeneity of OC underlies challenges in treatment (development) and patient stratification....
6.
Lof P, van Soolingen N, Piek J, Aarts J, Retel V, Bukman M, et al.
Gynecol Oncol
. 2024 Jun;
187:227-234.
PMID: 38823307
Objective: Treatment of advanced-stage ovarian cancer contains cytoreductive surgery (CRS) and chemotherapy. Achieving successful CRS (≤ 1 cm residual disease) is prognostically important, but may not be feasible peri-operatively while...
7.
Schreuder R, Stoop M, Piek J, van Lijnschoten G, Schoon E
BMJ Case Rep
. 2024 Feb;
17(2).
PMID: 38355211
A woman in her 70s with a medical history of recurrent ovarian carcinoma was referred to the gastroenterologist because of rectal blood loss. Colonoscopy revealed a spontaneously bleeding lesion, which...
8.
Pagan L, Huisman B, van der Wurff M, Naafs R, Schuren F, Sanders I, et al.
Front Microbiol
. 2023 Dec;
14:1264768.
PMID: 38094635
Background: The role of the vulvar microbiome in the development of (pre)malignant vulvar disease is scarcely investigated. The aim of this exploratory study was to analyze vulvar microbiome composition in...
9.
Nieuwenhuyzen-de Boer G, Aamran H, van den Berg C, Willemsen S, Piek J, Reesink-Peters N, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568763
Background: Knowledge of quality-of-life after cytoreductive surgery is important to counsel patients with advanced-stage epithelial ovarian cancer prior to surgery. The aim of this study was to determine whether the...
10.
Huisman B, Pagan L, Ulrich M, Rissmann R, Damman J, Piek J, et al.
Exp Dermatol
. 2023 Jul;
32(10):1734-1743.
PMID: 37486173
Incorrect and delayed diagnosis of vulvar high-grade squamous intraepithelial neoplasia (vHSIL) and lichen sclerosus (LS) increases malignant progression risks and negatively impacts prognosis and quality of life. There is a...